Andrew D.c. LaFrence - 15 Jul 2023 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Jul 2023, 20:52:35 UTC
Prior SEC filing
18 Jul 2023
Next SEC filing
05 Dec 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew D. C. LaFrence

Key filing fact

Andrew D.c. LaFrence filed Form 4 for KORU Medical Systems, Inc. (KRMD) on 18 Jul 2023.

Key facts

  • This page summarizes Andrew D.c. LaFrence's Form 4 filing for KORU Medical Systems, Inc. (KRMD).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 18 Jul 2023, 20:52.

Change

  • Previous filing in this sequence was filed on 18 Jul 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KRMD transaction Derivative

Options to Purchase Common Stock

Award

Transaction value
$0
Shares
+300,000
Change %
Price
$0.000000
Shares after
300,000
Date
15 Jul 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
300,000
Exercise price
$2.95
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Nonqualified stock options granted as an inducement to employment . Options vest in increments of 75,000 on the first anniversary of the date of grant and each anniversary thereafter until fully vested.

SEC remarks

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .